Skip to main content
. Author manuscript; available in PMC: 2021 Sep 1.
Published in final edited form as: Clin Transplant. 2020 Jul 24;34(9):e14017. doi: 10.1111/ctr.14017

Table 2.

Baseline demographics

Variable Total (n=21)1
Age (years) 62 [53–67]
Male 12 (57.1%)
Race/ethnicity
 White non-Hispanic 18 (85.7%)
 Black non-Hispanic 1 (4.5%)
 White Hispanic 1 (4.5%)
 Other 1 (4.5%)
CKD Stage 4 6 (28.6%)
CKD Stage 5
 Non-dialysis 1 (4.8%)
 Dialysis dependent 14 (66.7%)
Dialysis modality (n=14)
 Hemodialysis 11 (78.6%)
 Peritoneal dialysis 3 (21.4%)
Time on dialysis (years) (n=14) 3.0 [0.7–7.0]
Cause of ESRD
 Glomerulonephritis 1 (4.8%)
 Polycystic disease 3 (14.3%)
 Diabetes 8 (38.1%)
 Hypertension 3 (14.3%)
 Other 6 (28.6%)
History of prior kidney transplant, n (%) 3 (14.3%)
Comorbidities
 Diabetes 14 (66.7%)
 Cardiovascular disease 5 (23.8%)
 Peripheral vascular disease 8 (38.1%)
 Rheumatoid or other arthritis 4 (19.0%)
 Lower extremity amputation 0 (0.0%)
 Hypertension 19 (90.5%)
 History of cancer 6 (28.6%)
 Chronic obstructive pulmonary disease 5 (23.8%)
Smoking status
 Former smoker 5 (23.8%)
 Active smoker 0 (0%)
 Never smoked 16 (76.2%)
BMI (kg/m2) 30.5 [27.1–55.1]
Karnofsky score (baseline) 80 [70–80]
Evaluated for kidney transplant 18 (85.7%)
1

Median [IQR]